Home
Storia in 2 fonti
Merck scraps £1bn expansion in the UK over lack of state investment
The firm, known as MSD in Europe, said there has been a lack of investment in life sciences.
- ·
telegraph.co.uk
US drugmaker scraps plans for £1bn UK research centre
Merck criticises ‘successive UK governments’ as it cancels King’s Cross development
- ·
bbc.com
Merck scraps £1bn expansion in the UK over lack of state investment
The firm, known as MSD in Europe, said there has been a lack of investment in life sciences.
- ·
AstraZeneca pauses £200m Cambridge investment
Its decision comes as the industry says there is a lack of government investment and as the US pressures firms to invest there.